These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10328304)
1. New synthetic heparin mimetics able to inhibit thrombin and factor Xa. Petitou M; Duchaussoy P; Driguez PA; Hérault JP; Lormeau JC; Herbert JM Bioorg Med Chem Lett; 1999 Apr; 9(8):1155-60. PubMed ID: 10328304 [TBL] [Abstract][Full Text] [Related]
2. Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics. Petitou M; Driguez PA; Duchaussoy P; Hérault JP; Lormeau JC; Herbert JM Bioorg Med Chem Lett; 1999 Apr; 9(8):1161-6. PubMed ID: 10328305 [TBL] [Abstract][Full Text] [Related]
3. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
4. Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition. Duchaussoy P; Jaurand G; Driguez PA; Lederman I; Ceccato ML; Gourvenec F; Strassel JM; Sizun P; Petitou M; Herbert JM Carbohydr Res; 1999 Apr; 317(1-4):85-99. PubMed ID: 10466208 [TBL] [Abstract][Full Text] [Related]
5. Experimental proof for the structure of a thrombin-inhibiting heparin molecule. Petitou M; Imberty A; Duchaussoy P; Driguez PA; Ceccato ML; Gourvenec F; Sizun P; Hérault JP; Pérez S; Herbert JM Chemistry; 2001; 7(4):858-73. PubMed ID: 11288878 [TBL] [Abstract][Full Text] [Related]
6. Biological properties of synthetic glycoconjugate mimics of heparin comprising different molecular spacers. Dreef-Tromp CM; Basten JE; Broekhoven MA; van Dinther TG; Petitou M; van Boeckel CA Bioorg Med Chem Lett; 1998 Aug; 8(16):2081-6. PubMed ID: 9873490 [TBL] [Abstract][Full Text] [Related]
7. [New antithrombotic oligosaccharides]. Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858 [TBL] [Abstract][Full Text] [Related]
9. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity. Grootenhuis PD; Westerduin P; Meuleman D; Petitou M; van Boeckel CA Nat Struct Biol; 1995 Sep; 2(9):736-9. PubMed ID: 7552742 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma. Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466 [TBL] [Abstract][Full Text] [Related]
11. Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma. Schoen P; Lindhout T; Hemker HC Br J Haematol; 1992 Jun; 81(2):255-62. PubMed ID: 1322691 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of new synthetic heparin mimetics. Hérault JP; Bernat A; Roye F; Michaux C; Schaeffer P; Bono F; Petitou M; Herbert JM Thromb Haemost; 2002 Jun; 87(6):985-9. PubMed ID: 12083506 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans. Carson L; Doctor VM Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302 [TBL] [Abstract][Full Text] [Related]
16. Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'. Duchaussoy P; Jaurand G; Driguez PA; Lederman I; Gourvenec F; Strassel JM; Sizun P; Petitou M; Herbert JM Carbohydr Res; 1999 Apr; 317(1-4):63-84. PubMed ID: 10466207 [TBL] [Abstract][Full Text] [Related]
17. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues. Jeske W; Fareed J Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268 [TBL] [Abstract][Full Text] [Related]
18. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants. Fan B; Turko IV; Gettins PG Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827 [TBL] [Abstract][Full Text] [Related]
19. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Noti C; Seeberger PH Chem Biol; 2005 Jul; 12(7):731-56. PubMed ID: 16039522 [TBL] [Abstract][Full Text] [Related]
20. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa. Scully MF; Ellis V; Shah N; Kakkar V Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]